Table 1.

Summary of MDS-like/AML in SALL4B transgenic mice

Mouse ID	Sex	Founder	Age, mo	Phenotype	Outcome and organs involved by AML*
464	M	464	19	MDS-like	Died of MDS
4	M	464	22	MDS-like	Alive
504	M	504	19	MDS-like	Killed due to MDS
86	F	504	18	AML	Killed; AML in BM, PB, liver, spleen, LNs
87	F	504	8	AML	Killed; AML in BM, PB, liver, spleen, LNs
506	M	506	19	MDS-like	Killed due to MDS
1336	F	506	14	AML	Killed; AML in BM, liver, spleen, LNs
2548	F	506	14	AML	Killed; AML in BM, liver, spleen
507	F	507	24	AML	Died; AML in BM, PB, liver, spleen, LNs
23	M	507	22	MDS-like	Killed due to MDS
25	M	507	8	AML	Killed; AML in BM, PB, liver, spleen, LNs
26	M	507	14	MDS	Killed due to MDS
27	M	507	22	MDS-like	Alive
3058	F	507	12	AML	Died; AML in BM, PB, liver, spleen and LNs
509	F	509	18	AML	Killed; AML in BM, PB, liver, spleen, LNs, lung
510	F	510	24	MDS-like	Killed due to MDS

^*Mice were killed when noticed to be ill. AML is defined to have more than 20% c-kit-positive immature cells in the bone marrow or peripheral blood, with leukemia cells involving multiple organs